These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pharmacologic approaches for the management of patients with moderately elevated triglycerides (150-499 mg/dL). Kelly MS; Beavers C; Bucheit JD; Sisson EM; Dixon DL J Clin Lipidol; 2017; 11(4):872-879. PubMed ID: 28669686 [TBL] [Abstract][Full Text] [Related]
7. Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia. Mszar R; Bart S; Sakers A; Soffer D; Karalis DG J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835917 [TBL] [Abstract][Full Text] [Related]
8. Treatment options for the management of hypertriglyceridemia: strategies based on the best-available evidence. Maki KC; Bays HE; Dicklin MR J Clin Lipidol; 2012; 6(5):413-26. PubMed ID: 23009777 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory Links Between Hypertriglyceridemia and Atherogenesis. Peng X; Wu H Curr Atheroscler Rep; 2022 May; 24(5):297-306. PubMed ID: 35274230 [TBL] [Abstract][Full Text] [Related]
10. New approaches to triglyceride reduction: Is there any hope left? Filtz A; Parihar S; Greenberg GS; Park CM; Scotti A; Lorenzatti D; Badimon JJ; Soffer DE; Toth PP; Lavie CJ; Bittner V; Virani SS; Slipczuk L Am J Prev Cardiol; 2024 Jun; 18():100648. PubMed ID: 38584606 [TBL] [Abstract][Full Text] [Related]
11. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin. Breuer HW Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448 [TBL] [Abstract][Full Text] [Related]
12. Treatment of primary hypertriglyceridemia states--General approach and the role of extracorporeal methods. Stefanutti C; Julius U Atheroscler Suppl; 2015 May; 18():85-94. PubMed ID: 25936310 [TBL] [Abstract][Full Text] [Related]
13. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. Cziraky MJ; Watson KE; Talbert RL J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279 [TBL] [Abstract][Full Text] [Related]
14. Hypertriglyceridemia in an outpatient department--Significance as an atherosclerotic risk factor. Scholz M; Tselmin S; Fischer S; Julius U Atheroscler Suppl; 2015 May; 18():146-53. PubMed ID: 25936319 [TBL] [Abstract][Full Text] [Related]
16. Challenges in the treatment of hypertriglyceridemia: glass half empty or half full? Sahebkar A; Watts GF Expert Rev Clin Pharmacol; 2015; 8(4):363-6. PubMed ID: 26044648 [TBL] [Abstract][Full Text] [Related]
17. Egyptian practical guidance in hypertriglyceridemia management 2021. Taha HSED; Kandil H; Farag N; Oraby A; Sharkawy ME; Fawzy F; Mahrous H; Bahgat J; Samy M; Aboul M; Abdrabou M; Shaker MM Egypt Heart J; 2021 Dec; 73(1):107. PubMed ID: 34928475 [TBL] [Abstract][Full Text] [Related]
18. Omega-3 polyunsaturated fatty acids in the treatment of hypertriglyceridaemia. Pirillo A; Catapano AL Int J Cardiol; 2013 Dec; 170(2 Suppl 1):S16-20. PubMed ID: 23856442 [TBL] [Abstract][Full Text] [Related]
19. Double filtration plasmapheresis in the treatment of pancreatitis due to severe hypertriglyceridemia. Galán Carrillo I; Demelo-Rodriguez P; Rodríguez Ferrero ML; Anaya F J Clin Lipidol; 2015; 9(5):698-702. PubMed ID: 26350817 [TBL] [Abstract][Full Text] [Related]